Gossamer bio announces promotion of caryn peterson to executive vice president, regulatory affairs

San diego--(business wire)---- $goss--gossamer bio, inc. (nasdaq: goss), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced the promotion of caryn peterson to executive vice president, regulatory affairs. in this role, ms. peterson will continue to lead gossamer's regulatory and quality functions, tasked with strategizing and implementing global regulatory
GOSS Ratings Summary
GOSS Quant Ranking